Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radek C Skoda

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
The Hematology Journal : the Official Journal of the European Haematology Association|June 11, 2004
Chronic myeloproliferative disorders: molecular markers and pathogenesisRadek C Skoda
Hematology. American Society of Hematology. Education Program|December 17, 2009
ThrombocytosisRadek C Skoda
Blood|June 12, 2008
Can we control JAK?Radek C Skoda
Haematologica|January 13, 2010
Hereditary myeloproliferative disordersRadek C Skoda
Blood|December 29, 2018
Accelerating myelofibrosis through loss of <i>Dnmt3a</i>Radek C Skoda
Blood|September 4, 2010
JAK2 impairs stem cell function?Radek C Skoda
Blood|October 4, 2014
Less Jak2 makes more plateletsRadek C Skoda
The Journal of Experimental Medicine|March 21, 2019
Dual roles of <i>EZH2</i> in acute myeloid leukemiaRadek C Skoda, Juerg Schwaller
Blood Reviews|December 2, 2004
Molecular pathogenesis of Philadelphia chromosome negative myeloproliferative disordersRobert Kralovics, Radek C Skoda
Cancer Cell|February 15, 2011
HiJAKing the methylosome in myeloproliferative disordersRadek C Skoda, Jürg Schwaller
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
The Hematology Journal : the Official Journal of the European Haematology Association|June 11, 2004
Chronic myeloproliferative disorders: molecular markers and pathogenesisRadek C Skoda
Hematology. American Society of Hematology. Education Program|December 17, 2009
ThrombocytosisRadek C Skoda
Blood|June 12, 2008
Can we control JAK?Radek C Skoda
Haematologica|January 13, 2010
Hereditary myeloproliferative disordersRadek C Skoda
Blood|December 29, 2018
Accelerating myelofibrosis through loss of <i>Dnmt3a</i>Radek C Skoda
Blood|September 4, 2010
JAK2 impairs stem cell function?Radek C Skoda
Blood|October 4, 2014
Less Jak2 makes more plateletsRadek C Skoda
The Journal of Experimental Medicine|March 21, 2019
Dual roles of <i>EZH2</i> in acute myeloid leukemiaRadek C Skoda, Juerg Schwaller
Blood Reviews|December 2, 2004
Molecular pathogenesis of Philadelphia chromosome negative myeloproliferative disordersRobert Kralovics, Radek C Skoda
Cancer Cell|February 15, 2011
HiJAKing the methylosome in myeloproliferative disordersRadek C Skoda, Jürg Schwaller
Pageof 9